Global Anti-Infective Drugs Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Anti-Infective Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Anti-Infective Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 OTC
  • 1.2.3 Rx Drugs
• 1.3 Market by Application
  • 1.3.1 Global Anti-Infective Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospital
  • 1.3.3 Drugs Store
  • 1.3.4 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Anti-Infective Drugs Sales Estimates and Forecasts 2017-2028
• 2.2 Global Anti-Infective Drugs Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Anti-Infective Drugs Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Anti-Infective Drugs Sales by Region
  • 2.4.1 Global Anti-Infective Drugs Sales by Region (2017-2022)
  • 2.4.2 Global Sales Anti-Infective Drugs by Region (2023-2028)
• 2.5 Global Anti-Infective Drugs Revenue by Region
  • 2.5.1 Global Anti-Infective Drugs Revenue by Region (2017-2022)
  • 2.5.2 Global Anti-Infective Drugs Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Anti-Infective Drugs Sales by Manufacturers
  • 3.1.1 Global Top Anti-Infective Drugs Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Anti-Infective Drugs Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Infective Drugs in 2021
• 3.2 Global Anti-Infective Drugs Revenue by Manufacturers
  • 3.2.1 Global Anti-Infective Drugs Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Anti-Infective Drugs Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Anti-Infective Drugs Revenue in 2021
• 3.3 Global Anti-Infective Drugs Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Anti-Infective Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Anti-Infective Drugs Sales by Type
  • 4.1.1 Global Anti-Infective Drugs Historical Sales by Type (2017-2022)
  • 4.1.2 Global Anti-Infective Drugs Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• 4.2 Global Anti-Infective Drugs Revenue by Type
  • 4.2.1 Global Anti-Infective Drugs Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Anti-Infective Drugs Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• 4.3 Global Anti-Infective Drugs Price by Type
  • 4.3.1 Global Anti-Infective Drugs Price by Type (2017-2022)
  • 4.3.2 Global Anti-Infective Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Anti-Infective Drugs Sales by Application
  • 5.1.1 Global Anti-Infective Drugs Historical Sales by Application (2017-2022)
  • 5.1.2 Global Anti-Infective Drugs Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• 5.2 Global Anti-Infective Drugs Revenue by Application
  • 5.2.1 Global Anti-Infective Drugs Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Anti-Infective Drugs Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• 5.3 Global Anti-Infective Drugs Price by Application
  • 5.3.1 Global Anti-Infective Drugs Price by Application (2017-2022)
  • 5.3.2 Global Anti-Infective Drugs Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Anti-Infective Drugs Market Size by Type
  • 6.1.1 North America Anti-Infective Drugs Sales by Type (2017-2028)
  • 6.1.2 North America Anti-Infective Drugs Revenue by Type (2017-2028)
• 6.2 North America Anti-Infective Drugs Market Size by Application
  • 6.2.1 North America Anti-Infective Drugs Sales by Application (2017-2028)
  • 6.2.2 North America Anti-Infective Drugs Revenue by Application (2017-2028)
• 6.3 North America Anti-Infective Drugs Market Size by Country
  • 6.3.1 North America Anti-Infective Drugs Sales by Country (2017-2028)
  • 6.3.2 North America Anti-Infective Drugs Revenue by Country (2017-2028)
  • 6.3.3 the United States
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Anti-Infective Drugs Market Size by Type
  • 7.1.1 Europe Anti-Infective Drugs Sales by Type (2017-2028)
  • 7.1.2 Europe Anti-Infective Drugs Revenue by Type (2017-2028)
• 7.2 Europe Anti-Infective Drugs Market Size by Application
  • 7.2.1 Europe Anti-Infective Drugs Sales by Application (2017-2028)
  • 7.2.2 Europe Anti-Infective Drugs Revenue by Application (2017-2028)
• 7.3 Europe Anti-Infective Drugs Market Size by Country
  • 7.3.1 Europe Anti-Infective Drugs Sales by Country (2017-2028)
  • 7.3.2 Europe Anti-Infective Drugs Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 UK
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Anti-Infective Drugs Market Size by Type
  • 8.1.1 Asia Pacific Anti-Infective Drugs Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Anti-Infective Drugs Revenue by Type (2017-2028)
• 8.2 Asia Pacific Anti-Infective Drugs Market Size by Application
  • 8.2.1 Asia Pacific Anti-Infective Drugs Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Anti-Infective Drugs Revenue by Application (2017-2028)
• 8.3 Asia Pacific Anti-Infective Drugs Market Size by Region
  • 8.3.1 Asia Pacific Anti-Infective Drugs Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Anti-Infective Drugs Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Anti-Infective Drugs Market Size by Type
  • 9.1.1 Latin America Anti-Infective Drugs Sales by Type (2017-2028)
  • 9.1.2 Latin America Anti-Infective Drugs Revenue by Type (2017-2028)
• 9.2 Latin America Anti-Infective Drugs Market Size by Application
  • 9.2.1 Latin America Anti-Infective Drugs Sales by Application (2017-2028)
  • 9.2.2 Latin America Anti-Infective Drugs Revenue by Application (2017-2028)
• 9.3 Latin America Anti-Infective Drugs Market Size by Country
  • 9.3.1 Latin America Anti-Infective Drugs Sales by Country (2017-2028)
  • 9.3.2 Latin America Anti-Infective Drugs Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Anti-Infective Drugs Market Size by Type
  • 10.1.1 Middle East and Africa Anti-Infective Drugs Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Anti-Infective Drugs Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Anti-Infective Drugs Market Size by Application
  • 10.2.1 Middle East and Africa Anti-Infective Drugs Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Anti-Infective Drugs Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Anti-Infective Drugs Market Size by Country
  • 10.3.1 Middle East and Africa Anti-Infective Drugs Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Anti-Infective Drugs Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 GlaxoSmithKline
  • 11.1.1 GlaxoSmithKline Corporation Information
  • 11.1.2 GlaxoSmithKline Overview
  • 11.1.3 GlaxoSmithKline Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 GlaxoSmithKline Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 GlaxoSmithKline Recent Developments
• 11.2 Merck
  • 11.2.1 Merck Corporation Information
  • 11.2.2 Merck Overview
  • 11.2.3 Merck Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Merck Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Merck Recent Developments
• 11.3 Pfizer
  • 11.3.1 Pfizer Corporation Information
  • 11.3.2 Pfizer Overview
  • 11.3.3 Pfizer Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Pfizer Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Pfizer Recent Developments
• 11.4 Novartis AG
  • 11.4.1 Novartis AG Corporation Information
  • 11.4.2 Novartis AG Overview
  • 11.4.3 Novartis AG Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Novartis AG Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Novartis AG Recent Developments
• 11.5 Gilead Sciences
  • 11.5.1 Gilead Sciences Corporation Information
  • 11.5.2 Gilead Sciences Overview
  • 11.5.3 Gilead Sciences Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Gilead Sciences Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Gilead Sciences Recent Developments
• 11.6 Abbott
  • 11.6.1 Abbott Corporation Information
  • 11.6.2 Abbott Overview
  • 11.6.3 Abbott Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Abbott Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Abbott Recent Developments
• 11.7 Wyeth
  • 11.7.1 Wyeth Corporation Information
  • 11.7.2 Wyeth Overview
  • 11.7.3 Wyeth Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Wyeth Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Wyeth Recent Developments
• 11.8 Sanofi-Aventis
  • 11.8.1 Sanofi-Aventis Corporation Information
  • 11.8.2 Sanofi-Aventis Overview
  • 11.8.3 Sanofi-Aventis Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Sanofi-Aventis Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Sanofi-Aventis Recent Developments
• 11.9 Bristol-Myers Squibb
  • 11.9.1 Bristol-Myers Squibb Corporation Information
  • 11.9.2 Bristol-Myers Squibb Overview
  • 11.9.3 Bristol-Myers Squibb Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Bristol-Myers Squibb Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Bristol-Myers Squibb Recent Developments
• 11.10 Johnson
  • 11.10.1 Johnson Corporation Information
  • 11.10.2 Johnson Overview
  • 11.10.3 Johnson Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 Johnson Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Johnson Recent Developments
• 11.11 Roche Pharma AG
  • 11.11.1 Roche Pharma AG Corporation Information
  • 11.11.2 Roche Pharma AG Overview
  • 11.11.3 Roche Pharma AG Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Roche Pharma AG Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Roche Pharma AG Recent Developments
• 11.12 Nanosphere
  • 11.12.1 Nanosphere Corporation Information
  • 11.12.2 Nanosphere Overview
  • 11.12.3 Nanosphere Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Nanosphere Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Nanosphere Recent Developments
• 11.13 NanoViricides
  • 11.13.1 NanoViricides Corporation Information
  • 11.13.2 NanoViricides Overview
  • 11.13.3 NanoViricides Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 NanoViricides Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 NanoViricides Recent Developments
• 11.14 Novabay Pharmaceuticals
  • 11.14.1 Novabay Pharmaceuticals Corporation Information
  • 11.14.2 Novabay Pharmaceuticals Overview
  • 11.14.3 Novabay Pharmaceuticals Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 Novabay Pharmaceuticals Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 Novabay Pharmaceuticals Recent Developments
• 11.15 Obetech
  • 11.15.1 Obetech Corporation Information
  • 11.15.2 Obetech Overview
  • 11.15.3 Obetech Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 Obetech Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 Obetech Recent Developments
• 11.16 Optimer Pharmaceuticals
  • 11.16.1 Optimer Pharmaceuticals Corporation Information
  • 11.16.2 Optimer Pharmaceuticals Overview
  • 11.16.3 Optimer Pharmaceuticals Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.16.4 Optimer Pharmaceuticals Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Optimer Pharmaceuticals Recent Developments
• 11.17 Basilea Pharmaceutica AG
  • 11.17.1 Basilea Pharmaceutica AG Corporation Information
  • 11.17.2 Basilea Pharmaceutica AG Overview
  • 11.17.3 Basilea Pharmaceutica AG Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.17.4 Basilea Pharmaceutica AG Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 Basilea Pharmaceutica AG Recent Developments
• 11.18 Daiichi Sankyo
  • 11.18.1 Daiichi Sankyo Corporation Information
  • 11.18.2 Daiichi Sankyo Overview
  • 11.18.3 Daiichi Sankyo Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.18.4 Daiichi Sankyo Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.18.5 Daiichi Sankyo Recent Developments
• 11.19 MerLion Pharma
  • 11.19.1 MerLion Pharma Corporation Information
  • 11.19.2 MerLion Pharma Overview
  • 11.19.3 MerLion Pharma Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.19.4 MerLion Pharma Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.19.5 MerLion Pharma Recent Developments
• 11.20 Theravance
  • 11.20.1 Theravance Corporation Information
  • 11.20.2 Theravance Overview
  • 11.20.3 Theravance Anti-Infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.20.4 Theravance Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.20.5 Theravance Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Anti-Infective Drugs Industry Chain Analysis
• 12.2 Anti-Infective Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Anti-Infective Drugs Production Mode & Process
• 12.4 Anti-Infective Drugs Sales and Marketing
  • 12.4.1 Anti-Infective Drugs Sales Channels
  • 12.4.2 Anti-Infective Drugs Distributors
• 12.5 Anti-Infective Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Anti-Infective Drugs Industry Trends
• 13.2 Anti-Infective Drugs Market Drivers
• 13.3 Anti-Infective Drugs Market Challenges
• 13.4 Anti-Infective Drugs Market Restraints

14 Key Findings in The Global Anti-Infective Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Anti-Infective Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of OTC
• Table 3. Major Manufacturers of Rx Drugs
• Table 4. Global Anti-Infective Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Anti-Infective Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
• Table 7. Global Anti-Infective Drugs Sales Market Share by Region (2017-2022)
• Table 8. Global Anti-Infective Drugs Sales by Region (2023-2028) & (K Units)
• Table 9. Global Anti-Infective Drugs Sales Market Share by Region (2023-2028)
• Table 10. Global Anti-Infective Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Anti-Infective Drugs Revenue Market Share by Region (2017-2022)
• Table 12. Global Anti-Infective Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Anti-Infective Drugs Revenue Market Share by Region (2023-2028)
• Table 14. Global Anti-Infective Drugs Sales by Manufacturers (2017-2022) & (K Units)
• Table 15. Global Anti-Infective Drugs Sales Share by Manufacturers (2017-2022)
• Table 16. Global Anti-Infective Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Anti-Infective Drugs Revenue Share by Manufacturers (2017-2022)
• Table 18. Anti-Infective Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
• Table 19. Global Anti-Infective Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Anti-Infective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Infective Drugs as of 2021)
• Table 21. Anti-Infective Drugs Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Anti-Infective Drugs Product Offered
• Table 23. Date of Manufacturers Enter into Anti-Infective Drugs Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
• Table 26. Global Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
• Table 27. Global Anti-Infective Drugs Sales Share by Type (2017-2022)
• Table 28. Global Anti-Infective Drugs Sales Share by Type (2023-2028)
• Table 29. Global Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Anti-Infective Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Anti-Infective Drugs Revenue Share by Type (2017-2022)
• Table 32. Global Anti-Infective Drugs Revenue Share by Type (2023-2028)
• Table 33. Anti-Infective Drugs Price by Type (2017-2022) & (USD/Unit)
• Table 34. Global Anti-Infective Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
• Table 35. Global Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
• Table 36. Global Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
• Table 37. Global Anti-Infective Drugs Sales Share by Application (2017-2022)
• Table 38. Global Anti-Infective Drugs Sales Share by Application (2023-2028)
• Table 39. Global Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Anti-Infective Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Anti-Infective Drugs Revenue Share by Application (2017-2022)
• Table 42. Global Anti-Infective Drugs Revenue Share by Application (2023-2028)
• Table 43. Anti-Infective Drugs Price by Application (2017-2022) & (USD/Unit)
• Table 44. Global Anti-Infective Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
• Table 45. North America Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
• Table 46. North America Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
• Table 47. North America Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Anti-Infective Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
• Table 50. North America Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
• Table 51. North America Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Anti-Infective Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
• Table 54. North America Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
• Table 55. North America Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Anti-Infective Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
• Table 58. Europe Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
• Table 59. Europe Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Anti-Infective Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
• Table 62. Europe Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
• Table 63. Europe Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Anti-Infective Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
• Table 66. Europe Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
• Table 67. Europe Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Anti-Infective Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
• Table 70. Asia Pacific Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
• Table 71. Asia Pacific Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Anti-Infective Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
• Table 74. Asia Pacific Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
• Table 75. Asia Pacific Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Anti-Infective Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Anti-Infective Drugs Sales by Region (2017-2022) & (K Units)
• Table 78. Asia Pacific Anti-Infective Drugs Sales by Region (2023-2028) & (K Units)
• Table 79. Asia Pacific Anti-Infective Drugs Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Anti-Infective Drugs Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
• Table 82. Latin America Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
• Table 83. Latin America Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Anti-Infective Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
• Table 86. Latin America Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
• Table 87. Latin America Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Anti-Infective Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
• Table 90. Latin America Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
• Table 91. Latin America Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Anti-Infective Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Anti-Infective Drugs Sales by Type (2017-2022) & (K Units)
• Table 94. Middle East and Africa Anti-Infective Drugs Sales by Type (2023-2028) & (K Units)
• Table 95. Middle East and Africa Anti-Infective Drugs Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Anti-Infective Drugs Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Anti-Infective Drugs Sales by Application (2017-2022) & (K Units)
• Table 98. Middle East and Africa Anti-Infective Drugs Sales by Application (2023-2028) & (K Units)
• Table 99. Middle East and Africa Anti-Infective Drugs Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Anti-Infective Drugs Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Anti-Infective Drugs Sales by Country (2017-2022) & (K Units)
• Table 102. Middle East and Africa Anti-Infective Drugs Sales by Country (2023-2028) & (K Units)
• Table 103. Middle East and Africa Anti-Infective Drugs Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Anti-Infective Drugs Revenue by Country (2023-2028) & (US$ Million)
• Table 105. GlaxoSmithKline Corporation Information
• Table 106. GlaxoSmithKline Description and Major Businesses
• Table 107. GlaxoSmithKline Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 108. GlaxoSmithKline Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. GlaxoSmithKline Recent Developments
• Table 110. Merck Corporation Information
• Table 111. Merck Description and Major Businesses
• Table 112. Merck Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 113. Merck Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Merck Recent Developments
• Table 115. Pfizer Corporation Information
• Table 116. Pfizer Description and Major Businesses
• Table 117. Pfizer Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 118. Pfizer Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Pfizer Recent Developments
• Table 120. Novartis AG Corporation Information
• Table 121. Novartis AG Description and Major Businesses
• Table 122. Novartis AG Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 123. Novartis AG Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Novartis AG Recent Developments
• Table 125. Gilead Sciences Corporation Information
• Table 126. Gilead Sciences Description and Major Businesses
• Table 127. Gilead Sciences Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 128. Gilead Sciences Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Gilead Sciences Recent Developments
• Table 130. Abbott Corporation Information
• Table 131. Abbott Description and Major Businesses
• Table 132. Abbott Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 133. Abbott Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Abbott Recent Developments
• Table 135. Wyeth Corporation Information
• Table 136. Wyeth Description and Major Businesses
• Table 137. Wyeth Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 138. Wyeth Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. Wyeth Recent Developments
• Table 140. Sanofi-Aventis Corporation Information
• Table 141. Sanofi-Aventis Description and Major Businesses
• Table 142. Sanofi-Aventis Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 143. Sanofi-Aventis Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Sanofi-Aventis Recent Developments
• Table 145. Bristol-Myers Squibb Corporation Information
• Table 146. Bristol-Myers Squibb Description and Major Businesses
• Table 147. Bristol-Myers Squibb Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 148. Bristol-Myers Squibb Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Bristol-Myers Squibb Recent Developments
• Table 150. Johnson Corporation Information
• Table 151. Johnson Description and Major Businesses
• Table 152. Johnson Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 153. Johnson Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. Johnson Recent Developments
• Table 155. Roche Pharma AG Corporation Information
• Table 156. Roche Pharma AG Description and Major Businesses
• Table 157. Roche Pharma AG Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 158. Roche Pharma AG Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Roche Pharma AG Recent Developments
• Table 160. Nanosphere Corporation Information
• Table 161. Nanosphere Description and Major Businesses
• Table 162. Nanosphere Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 163. Nanosphere Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. Nanosphere Recent Developments
• Table 165. NanoViricides Corporation Information
• Table 166. NanoViricides Description and Major Businesses
• Table 167. NanoViricides Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 168. NanoViricides Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 169. NanoViricides Recent Developments
• Table 170. Novabay Pharmaceuticals Corporation Information
• Table 171. Novabay Pharmaceuticals Description and Major Businesses
• Table 172. Novabay Pharmaceuticals Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 173. Novabay Pharmaceuticals Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 174. Novabay Pharmaceuticals Recent Developments
• Table 175. Obetech Corporation Information
• Table 176. Obetech Description and Major Businesses
• Table 177. Obetech Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 178. Obetech Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 179. Obetech Recent Developments
• Table 180. Optimer Pharmaceuticals Corporation Information
• Table 181. Optimer Pharmaceuticals Description and Major Businesses
• Table 182. Optimer Pharmaceuticals Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 183. Optimer Pharmaceuticals Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 184. Optimer Pharmaceuticals Recent Developments
• Table 185. Basilea Pharmaceutica AG Corporation Information
• Table 186. Basilea Pharmaceutica AG Description and Major Businesses
• Table 187. Basilea Pharmaceutica AG Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 188. Basilea Pharmaceutica AG Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 189. Basilea Pharmaceutica AG Recent Developments
• Table 190. Daiichi Sankyo Corporation Information
• Table 191. Daiichi Sankyo Description and Major Businesses
• Table 192. Daiichi Sankyo Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 193. Daiichi Sankyo Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 194. Daiichi Sankyo Recent Developments
• Table 195. MerLion Pharma Corporation Information
• Table 196. MerLion Pharma Description and Major Businesses
• Table 197. MerLion Pharma Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 198. MerLion Pharma Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 199. MerLion Pharma Recent Developments
• Table 200. Theravance Corporation Information
• Table 201. Theravance Description and Major Businesses
• Table 202. Theravance Anti-Infective Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
• Table 203. Theravance Anti-Infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications
• Table 204. Theravance Recent Developments
• Table 205. Key Raw Materials Lists
• Table 206. Raw Materials Key Suppliers Lists
• Table 207. Anti-Infective Drugs Distributors List
• Table 208. Anti-Infective Drugs Customers List
• Table 209. Anti-Infective Drugs Market Trends
• Table 210. Anti-Infective Drugs Market Drivers
• Table 211. Anti-Infective Drugs Market Challenges
• Table 212. Anti-Infective Drugs Market Restraints
• Table 213. Research Programs/Design for This Report
• Table 214. Key Data Information from Secondary Sources
• Table 215. Key Data Information from Primary Sources

List of Figures

• Figure 1. Anti-Infective Drugs Product Picture
• Figure 3. Global Anti-Infective Drugs Market Share by Type in 2021 & 2028
• Figure 3. OTC Product Picture
• Figure 4. Rx Drugs Product Picture
• Figure 5. Global Anti-Infective Drugs Market Share by Application in 2021 & 2028
• Figure 6. Hospital
• Figure 7. Drugs Store
• Figure 8. Other
• Figure 9. Anti-Infective Drugs Report Years Considered
• Figure 10. Global Anti-Infective Drugs Sales 2017-2028 (K Units)
• Figure 11. Global Anti-Infective Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Anti-Infective Drugs Revenue 2017-2028 (US$ Million)
• Figure 13. Global Anti-Infective Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Anti-Infective Drugs Sales Market Share by Region (2017-2022)
• Figure 15. Global Anti-Infective Drugs Sales Market Share by Region (2023-2028)
• Figure 16. North America Anti-Infective Drugs Sales YoY (2017-2028) & (K Units)
• Figure 17. North America Anti-Infective Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Anti-Infective Drugs Sales YoY (2017-2028) & (K Units)
• Figure 19. Europe Anti-Infective Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Anti-Infective Drugs Sales YoY (2017-2028) & (K Units)
• Figure 21. Asia-Pacific Anti-Infective Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Anti-Infective Drugs Sales YoY (2017-2028) & (K Units)
• Figure 23. Latin America Anti-Infective Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Anti-Infective Drugs Sales YoY (2017-2028) & (K Units)
• Figure 25. Middle East & Africa Anti-Infective Drugs Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Anti-Infective Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Anti-Infective Drugs in the World: Market Share by Anti-Infective Drugs Revenue in 2021
• Figure 28. Global Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• Figure 30. Global Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• Figure 31. Global Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• Figure 32. Global Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• Figure 33. North America Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• Figure 34. North America Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• Figure 35. North America Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• Figure 36. North America Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• Figure 37. North America Anti-Infective Drugs Sales Share by Country (2017-2028)
• Figure 38. North America Anti-Infective Drugs Revenue Share by Country (2017-2028)
• Figure 39. the United States Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• Figure 42. Europe Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• Figure 43. Europe Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• Figure 44. Europe Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Anti-Infective Drugs Sales Share by Country (2017-2028)
• Figure 46. Europe Anti-Infective Drugs Revenue Share by Country (2017-2028)
• Figure 47. Germany Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 48. France Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 49. UK Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• Figure 54. Asia Pacific Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Anti-Infective Drugs Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Anti-Infective Drugs Revenue Share by Region (2017-2028)
• Figure 58. China Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 61. India Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 63. China Taiwan Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 67. Latin America Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• Figure 68. Latin America Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• Figure 69. Latin America Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• Figure 70. Latin America Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• Figure 71. Latin America Anti-Infective Drugs Sales Share by Country (2017-2028)
• Figure 72. Latin America Anti-Infective Drugs Revenue Share by Country (2017-2028)
• Figure 73. Mexico Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 74. Brazil Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 75. Argentina Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 76. Middle East and Africa Anti-Infective Drugs Sales Market Share by Type (2017-2028)
• Figure 77. Middle East and Africa Anti-Infective Drugs Revenue Market Share by Type (2017-2028)
• Figure 78. Middle East and Africa Anti-Infective Drugs Sales Market Share by Application (2017-2028)
• Figure 79. Middle East and Africa Anti-Infective Drugs Revenue Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Anti-Infective Drugs Sales Share by Country (2017-2028)
• Figure 81. Middle East and Africa Anti-Infective Drugs Revenue Share by Country (2017-2028)
• Figure 82. Turkey Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 83. Saudi Arabia Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 84. UAE Anti-Infective Drugs Revenue (2017-2028) & (US$ Million)
• Figure 85. Anti-Infective Drugs Value Chain
• Figure 86. Anti-Infective Drugs Production Process
• Figure 87. Channels of Distribution
• Figure 88. Distributors Profiles
• Figure 89. Bottom-up and Top-down Approaches for This Report
• Figure 90. Data Triangulation
• Figure 91. Key Executives Interviewed